Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Immunoassay Systems. Global market for Immunoassay Systems is projected to reach US$17.9 billion by 2020, driven by aging population, rise in chronic & infectious diseases, development of novel biomarkers, robust demand for non-invasive diagnostic tools, and improved access to healthcare & testing services in developing countries.

Immunoassay Systems: A Global Strategic Business Report

Follow us on LinkedIn – Immunoassays are ligand assays used for detection and quantification of the presence of antigens and antibodies in a given sample. Driven by steady expansion in immunodiagnostics and technological advancements in the overall healthcare industry, the global immunoassay systems market has evolved remarkably well over the years. Rising incidence of debilitating conditions, such as diabetes, cardio-vascular ailments, infectious diseases, allergy and cancer, continue to fuel the demand for immunoassay analyzers. Increasing healthcare needs of an aging population worldwide and growing demand for non-invasive diagnostic techniques bodes well for the market. Increasing emphasis on preventive care among the general populace and policy makers also represents a favorable growth factor.

Infectious diseases form the largest application for immunoassays, representing more than 30% of the market. In the coming years, application of immunoassays in oncology is expected to improve significantly led by rising incidence of cancer, increased emphasis on early diagnosis of the disease and development of a wide array of cancer biomarkers. Increasing focus on drug screening procedures is also expected to benefit growth. Bone metabolism markers, cardiac markers and tumor markers are some of the most lucrative segments in immunoassays.

Enzyme-Linked Immunosorbent Assay (ELISA) is one of the few assay formats commanding widespread popularity, in terms of reproducibility, performance and validation. However, advanced multiplex technology with multiple-analyte quantification technique continues to gain popularity over the single-analyte technique of ELISA. Of late, a large number of laboratories have been shifting to automated multiplexing technology on account of improved lab workflows and reduced turnaround times. Market participants are also developing novel assays for point-of-care (POC) testing. Manufacturers have been focusing on creating smaller, sleeker, intuitive and easy-to-use instruments for addressing the needs of decentralized testing. This emerging trend is in turn fueling demand for Lateral flow assays. Lateral flow assays are expected to contribute immensely to the growth of the global immunoassays market.

As stated by the new market research report on Immunoassay Systems, the United States represents the largest market worldwide. Asia-Pacific is projected to witness the fastest growth with a CAGR of 10.4% over the analysis period. Emerging nations such as China, India, and Brazil present significant opportunities for growth supported by improving healthcare infrastructure, rise in number of clinical testing laboratories, increasing healthcare expenditure, and growing incidence of chronic diseases.

Major players covered in the report include Abbott Laboratories, Beckman Coulter Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., Roche Diagnostics, Siemens Healthcare Diagnostics, Sysmex Corporation, Quidel Corporation, DiaSorin S.p.A, and Tosoh Bioscience Inc., among others.

The research report titled “Immunoassay Systems: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of major companies worldwide. The report provides market estimates and projections for all major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America), and Rest of World. Product segments analyzed include Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems.

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site:


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website